In the GWAS of the CEF-treated group, genetic variants in the ALOX5AP gene on chromosome 13 were most significantly associated with chemotherapy-induced alopecia (rs3885907, minimum P = 1.38 × 10-6, OR = 2.66, 95% CI: 1.71 to 4.13). This evidence concerns the gene ALOX5AP and alopecia.